The definitive directory of AI-native and computational drug discovery companies, spanning generative chemistry, computational biology, target identification, protein design, clinical AI, drug repurposing, and phenomics and high-content screening. Curated for biotech investors, pharma partners scouting AI platforms, and scientists tracking machine learning in drug development.
BioMed Nexus tracks 161 AI drug discovery companies across 7 categories: generative chemistry, computational biology, target identification, protein design, clinical AI, drug repurposing, and phenomics & screening. The directory covers the leading AI-native drug discovery companies, including Recursion, Insilico Medicine, Schrödinger, Relay Therapeutics, Atomwise and Absci, alongside emerging startups. Last updated July 2026
Priority placement at the top of the directory, a dedicated landing page, and a featured newsletter segment reaching 65,000+ subscribers. Limited spots available.
Right now, every company in this directory is just a name in a database. Featured partners get a full profile with logo, platform, pipeline, backlinks, and priority placement at the very top of this page, seen by 65,000+ biotech professionals every week. Claim the top spot before your competitors do.
The BioMed Nexus AI Drug Discovery Companies Directory is a comprehensive, regularly updated list of AI-native and computational drug discovery companies, spanning generative chemistry, computational biology, target identification, protein design and engineering, clinical AI, drug repurposing, and phenomics and high-content screening. It covers the leading AI drug discovery companies alongside emerging startups applying machine learning to therapeutics.
Use it to research AI drug discovery companies by approach, track the competitive landscape, and map platform and partnership opportunities. Whether you are a biotech investor evaluating the AI drug discovery sector, a pharma partner scouting AI platforms, or a scientist tracking machine learning in drug development, the directory provides structured, current company data. Curated and maintained by the BioMed Nexus editorial team; last updated July 2026.
Companies can claim a free basic listing or become a Featured Partner for priority placement, a dedicated landing page, backlinks, and a featured segment in the BioMed Nexus daily newsletter reaching 65,000+ subscribers. Contact our partnerships team to learn more.
